Experts debate when to initiate ART in asymptomatic HIV

Experts debate when to initiate ART in asymptomatic HIV

No trial has demonstrated net benefit from use of ART above currently accepted CD4 count thresholds (350 cells/mcL), and the completed observation studies do not support the claim of benefit either, according to Lundgren, who added that there are also no data to support early ART in resource-limited...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Infectious Disease News 2012-12, Vol.25 (12), p.20
Hauptverfasser: Henry, Jennifer, Kalvaitis, Katie
Format: Artikel
Sprache:eng
Schlagworte:
Acquired immune deficiency syndrome
AIDS
Colleges & universities
Debates
HIV
Human immunodeficiency virus
Patients
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 12
container_start_page 20
container_title Infectious Disease News
container_volume 25
creator Henry, Jennifer
Kalvaitis, Katie
description No trial has demonstrated net benefit from use of ART above currently accepted CD4 count thresholds (350 cells/mcL), and the completed observation studies do not support the claim of benefit either, according to Lundgren, who added that there are also no data to support early ART in resource-limited settings.
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_reports_1270214553</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2867457691</sourcerecordid><originalsourceid>FETCH-proquest_reports_12702145533</originalsourceid><addsrcrecordid>eNpjYeA0NDA107U0MjXkYOAqLs4yMDAxNjUx5mQwd60oSC0qKVZISU1KLElVKM9IzVMoyVfIzMssyQQJOAaFADkKicWVuQUl-bmJJZnJCh6eYTwMrGmJOcWpvFCam0HJzTXE2UO3oCi_sDS1uCS-KLUgH2hwvKGRuYGRoYmpqbExUYoA6mQznA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1270214553</pqid></control><display><type>article</type><title>Experts debate when to initiate ART in asymptomatic HIV</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Henry, Jennifer ; Kalvaitis, Katie</creator><creatorcontrib>Henry, Jennifer ; Kalvaitis, Katie</creatorcontrib><description>No trial has demonstrated net benefit from use of ART above currently accepted CD4 count thresholds (350 cells/mcL), and the completed observation studies do not support the claim of benefit either, according to Lundgren, who added that there are also no data to support early ART in resource-limited settings.</description><identifier>ISSN: 1056-9251</identifier><language>eng</language><publisher>Thorofare: SLACK INCORPORATED</publisher><subject>Acquired immune deficiency syndrome ; AIDS ; Colleges &amp; universities ; Debates ; HIV ; Human immunodeficiency virus ; Patients</subject><ispartof>Infectious Disease News, 2012-12, Vol.25 (12), p.20</ispartof><rights>Copyright SLACK INCORPORATED Dec 2012</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>312,776,780,787</link.rule.ids></links><search><creatorcontrib>Henry, Jennifer</creatorcontrib><creatorcontrib>Kalvaitis, Katie</creatorcontrib><title>Experts debate when to initiate ART in asymptomatic HIV</title><title>Infectious Disease News</title><description>No trial has demonstrated net benefit from use of ART above currently accepted CD4 count thresholds (350 cells/mcL), and the completed observation studies do not support the claim of benefit either, according to Lundgren, who added that there are also no data to support early ART in resource-limited settings.</description><subject>Acquired immune deficiency syndrome</subject><subject>AIDS</subject><subject>Colleges &amp; universities</subject><subject>Debates</subject><subject>HIV</subject><subject>Human immunodeficiency virus</subject><subject>Patients</subject><issn>1056-9251</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpjYeA0NDA107U0MjXkYOAqLs4yMDAxNjUx5mQwd60oSC0qKVZISU1KLElVKM9IzVMoyVfIzMssyQQJOAaFADkKicWVuQUl-bmJJZnJCh6eYTwMrGmJOcWpvFCam0HJzTXE2UO3oCi_sDS1uCS-KLUgH2hwvKGRuYGRoYmpqbExUYoA6mQznA</recordid><startdate>20121201</startdate><enddate>20121201</enddate><creator>Henry, Jennifer</creator><creator>Kalvaitis, Katie</creator><general>SLACK INCORPORATED</general><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>20121201</creationdate><title>Experts debate when to initiate ART in asymptomatic HIV</title><author>Henry, Jennifer ; Kalvaitis, Katie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_reports_12702145533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>AIDS</topic><topic>Colleges &amp; universities</topic><topic>Debates</topic><topic>HIV</topic><topic>Human immunodeficiency virus</topic><topic>Patients</topic><toplevel>online_resources</toplevel><creatorcontrib>Henry, Jennifer</creatorcontrib><creatorcontrib>Kalvaitis, Katie</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Infectious Disease News</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Henry, Jennifer</au><au>Kalvaitis, Katie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Experts debate when to initiate ART in asymptomatic HIV</atitle><jtitle>Infectious Disease News</jtitle><date>2012-12-01</date><risdate>2012</risdate><volume>25</volume><issue>12</issue><spage>20</spage><pages>20-</pages><issn>1056-9251</issn><abstract>No trial has demonstrated net benefit from use of ART above currently accepted CD4 count thresholds (350 cells/mcL), and the completed observation studies do not support the claim of benefit either, according to Lundgren, who added that there are also no data to support early ART in resource-limited settings.</abstract><cop>Thorofare</cop><pub>SLACK INCORPORATED</pub></addata></record>
fulltext fulltext
identifier ISSN: 1056-9251
ispartof Infectious Disease News, 2012-12, Vol.25 (12), p.20
issn 1056-9251
language eng
recordid cdi_proquest_reports_1270214553
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Acquired immune deficiency syndrome
AIDS
Colleges & universities
Debates
HIV
Human immunodeficiency virus
Patients
title Experts debate when to initiate ART in asymptomatic HIV
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T01%3A56%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Experts%20debate%20when%20to%20initiate%20ART%20in%20asymptomatic%20HIV&rft.jtitle=Infectious%20Disease%20News&rft.au=Henry,%20Jennifer&rft.date=2012-12-01&rft.volume=25&rft.issue=12&rft.spage=20&rft.pages=20-&rft.issn=1056-9251&rft_id=info:doi/&rft_dat=%3Cproquest%3E2867457691%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1270214553&rft_id=info:pmid/&rfr_iscdi=true